Wells Fargo & Company MN decreased its stake in athenahealth Inc. (NASDAQ:ATHN) by 4.4% during the third quarter, Holdings Channel reports. The firm owned 105,906 shares of the company’s stock after selling 4,911 shares during the period. Wells Fargo & Company MN’s holdings in athenahealth were worth $13,357,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in ATHN. Advisor Group Inc. purchased a new stake in athenahealth during the second quarter valued at about $118,000. First Quadrant L P CA purchased a new stake in athenahealth during the third quarter valued at about $114,000. FineMark National Bank & Trust boosted its stake in athenahealth by 4.5% in the second quarter. FineMark National Bank & Trust now owns 944 shares of the company’s stock valued at $130,000 after buying an additional 41 shares during the period. KBC Group NV purchased a new stake in athenahealth during the second quarter valued at about $135,000. Finally, Societe Generale purchased a new stake in athenahealth during the second quarter valued at about $176,000.
Shares of athenahealth Inc. (NASDAQ:ATHN) traded down 1.42% on Monday, reaching $100.93. 530,203 shares of the company’s stock traded hands. The firm has a market capitalization of $3.98 billion, a price-to-earnings ratio of 215.20 and a beta of 1.85. athenahealth Inc. has a 52 week low of $97.70 and a 52 week high of $170.42. The company has a 50 day moving average price of $109.56 and a 200 day moving average price of $123.40.
athenahealth (NASDAQ:ATHN) last posted its quarterly earnings results on Thursday, October 20th. The company reported $0.60 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.47 by $0.13. athenahealth had a net margin of 1.80% and a return on equity of 6.60%. The business earned $276.70 million during the quarter. During the same period last year, the firm posted $0.36 earnings per share. The company’s quarterly revenue was up 17.2% on a year-over-year basis. On average, equities research analysts predict that athenahealth Inc. will post $1.74 earnings per share for the current fiscal year.
Several brokerages recently commented on ATHN. Oppenheimer Holdings Inc. set a $170.00 price target on shares of athenahealth and gave the stock a “buy” rating in a research note on Thursday, October 20th. Canaccord Genuity reiterated a “hold” rating and set a $127.00 price target on shares of athenahealth in a research note on Sunday, October 23rd. JPMorgan Chase & Co. lowered shares of athenahealth from an “overweight” rating to a “neutral” rating and cut their price target for the stock from $128.00 to $111.00 in a research note on Friday, October 28th. Zacks Investment Research upgraded shares of athenahealth from a “sell” rating to a “hold” rating in a research note on Thursday, August 4th. Finally, Jefferies Group lifted their price target on shares of athenahealth from $105.00 to $110.00 and gave the stock an “underperform” rating in a research note on Friday, October 14th. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and six have issued a buy rating to the company. athenahealth presently has a consensus rating of “Hold” and an average target price of $140.26.
In related news, VP Karl Stubelis sold 928 shares of athenahealth stock in a transaction dated Wednesday, September 7th. The shares were sold at an average price of $123.36, for a total value of $114,478.08. Following the sale, the vice president now directly owns 1,375 shares in the company, valued at approximately $169,620. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director John A. Kane sold 5,750 shares of athenahealth stock in a transaction dated Thursday, October 27th. The shares were sold at an average price of $122.63, for a total transaction of $705,122.50. The disclosure for this sale can be found here. 3.04% of the stock is currently owned by insiders.
athenahealth Company Profile
athenahealth, Inc is a provider of cloud-based services and mobile applications for medical groups and health systems. The Company delivers cloud-based services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, care coordination, order transmission, population health management, and clinical decision support.